Regulus Therapeutics, Inc. Reports First Quarter 2014 Financial Results And Recent Highlights
5/9/2014 6:47:22 AM
LA JOLLA, Calif., May 8, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results and highlights for the quarter ended March 31, 2014 and provided a summary of recent corporate highlights.
Help employers find you! Check out all the jobs and post your resume.
comments powered by